Egypt
Cardiac Monitoring & Cardiac Rhythm Management Devices market is expected
to grow at an impressive rate during the forecast period 2024-2028. The market is driven by
a variety of factors, including technological advancements, growing prevalence
of cardiovascular diseases, increasing demand for remote patient monitoring,
and rising healthcare expenditure. Moreover, these devices are essential for
accurately diagnosing and managing heart conditions, including arrhythmias,
heart failure, and other cardiac disorders.
Cardiac
monitoring devices monitor a patient's heart rhythm over a period, usually 24
to 48 hours, and record any irregularities or abnormalities. These recordings
are then analyzed by a physician to help diagnose arrhythmias and other heart
conditions in the patient. Similarly, cardiac rhythm management devices are
also used to help manage heart conditions in people suspecting heart health
issues. These devices include pacemakers and implantable cardioverter
defibrillators (ICDs). Pacemakers are used to help regulate the heart's rhythm
by sending electrical signals to the heart when it beats too slowly or
irregularly. ICDs, on the other hand, are used to treat life-threatening
arrhythmias by delivering a shock to the heart when needed. Cardiac monitoring
plays a critical role in the diagnosis, management, and prevention of heart
conditions. It enables healthcare providers to provide timely and effective
treatment, while also improving patient outcomes.
Egyptian healthcare
providers also use cardiac resynchronization therapy (CRT) devices, which are a
type of pacemaker that help coordinate the contractions of the heart's
ventricles. CRT devices are used to treat heart failure and other cardiac
conditions by improving heart's efficiency and reducing symptoms. Cardiac
monitoring plays an important role in the diagnosis and management of heart
conditions. It involves the use of various devices and technologies to
continuously monitor the heart's activity and detect any abnormalities or
irregularities in its rhythm. Cardiac monitoring is essential for the early
detection of heart conditions such as arrhythmias, heart failure, and coronary
artery disease. By continuously monitoring the heart's activity, healthcare
providers can quickly identify any changes or irregularities in its rhythm,
enabling early intervention and treatment.
Moreover, cardiac
monitoring devices can be used to monitor patients remotely, allowing for more
convenient and accessible care. Remote monitoring is especially important for
patients who live in remote or underserved areas and may have limited access to
healthcare services.
Furthermore, cardiac
monitoring is an important tool for research and development in the field of
cardiology. By collecting and analyzing data from cardiac monitoring devices,
researchers can gain valuable insights into the mechanisms of heart disease and
develop new treatments and therapies.
Growing
Cardiovascular Diseases in Egypt
Egypt is facing a
growing burden of cardiovascular diseases, which are responsible for a
significant proportion of morbidity and mortality in the country. According to
the World Health Organization, cardiovascular diseases are the leading cause of
death in Egypt. Cardiovascular health is a major public health concern in
Egypt, with a high prevalence of cardiovascular disease and associated risk
factors. According to the World Health Organization (WHO), in 2017,
cardiovascular diseases are the leading cause of death in Egypt, accounting for
approximately 46.2% of all deaths. As the population ages and lifestyles
become more sedentary, the incidence of cardiovascular diseases such as
arrhythmias, heart failure, and coronary artery disease is on the rise. This
has led to an increasing demand for cardiac monitoring and cardiac rhythm
management devices to accurately diagnose and manage these conditions. Several
factors contribute to the high prevalence of cardiovascular disease in Egypt,
including a high prevalence of smoking, physical inactivity, and unhealthy
diets. Additionally, obesity and diabetes are major risk factors for
cardiovascular disease, and both conditions are prevalent in Egypt.
The burden of
cardiovascular disease in Egypt is also intensified by inadequate healthcare
infrastructure and limited access to care, particularly in rural areas. This
makes it difficult for patients to receive timely and effective treatment for
heart conditions, resulting in poor outcomes and increased morbidity and mortality.
The high prevalence of
risk factors for cardiovascular diseases, such as hypertension, diabetes,
obesity, and tobacco use, are contributing to the increasing incidence of
cardiovascular diseases in Egypt. According to the WHO, the current prevalence
of hypertension in Egypt is estimated to be as high as 40%, while the
prevalence of diabetes is estimated to be around 17%.
Additionally, lifestyle
factors such as physical inactivity, unhealthy diet, and stress are also
contributing to the growing incidence of cardiovascular diseases in Egypt. In
addition, the burden of cardiovascular diseases is also increased by limited
access to healthcare services and inadequate prevention and management
strategies. There is a shortage of healthcare professionals and resources in
Egypt, which leads to limited treatment opportunities for the patients
suffering from chronic health conditions.
To address the growing
burden of cardiovascular diseases in Egypt, there is a need for improved
prevention and management strategies, including greater emphasis on promoting
healthy lifestyles and better access to healthcare services. This includes
increasing awareness of risk factors and early detection and management of
cardiovascular diseases using advanced cardiac monitoring and cardiac rhythm
management devices. By addressing these challenges, it is possible to improve
the health outcomes of individuals in Egypt and reduce the burden of
cardiovascular diseases on the healthcare system.
Technological
Advancement
Technological
advancements are improving the accuracy, efficiency, and convenience of cardiac
monitoring, diagnosis, and management of cardiac conditions. Several significant
technological advancements in cardiac monitoring like real time monitoring of
patients, are being developed which are contributing to the growth of cardiac
monitoring & cardiac rhythm management devices. These technologies allow
for real-time monitoring of patients, enabling healthcare providers to access
important patient data and make informed decisions quickly. Remote monitoring
is especially important for patients who live in remote or underserved areas
and may have limited access to healthcare services.
Also, technological
advancement such as the development of wearable cardiac monitoring devices, is
propelling the cardiac monitoring & cardiac rhythm management devices. These
devices are small, portable, and can be worn continuously, allowing for
continuous monitoring of the heart's activity. They can also provide patients
with real-time feedback on their heart rate, rhythm, and activity levels,
empowering them to take control of their own health. Other advancements in
cardiac rhythm management devices include the development of implantable
cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT)
devices. ICDs are small devices implanted under the skin that monitor the
heart's rhythm and deliver an electrical shock if an abnormal rhythm is
detected, while CRT devices are used to improve the synchronization of the
heart's chambers in patients with heart failure.
Furthermore, important
technological advancement is the development of artificial intelligence (AI)
and machine learning algorithms in cardiac devices. These technologies are
being used to analyze large amounts of cardiac monitoring data, enabling healthcare
providers to identify patterns and detect early warning signs of heart
conditions. This technology can also be used to develop personalized treatment
plans for patients based on their individual health data.
These advancements are
improving the accuracy and efficiency of diagnosis and treatment, as well as
empowering patients to take control of their own health and thereby create a
huge opportunity for the cardiac monitoring & cardiac rhythm management
devices in the forecast period.
Growing Government
Measures and Regulations To Prevent CVDs.
The government has led to
increased awareness and improved healthcare infrastructure of the country and
has led to the development of several measures controlling the spread and
development of cardiovascular diseases (CVDs) in the country.
One of the significant
measures taken by the government and healthcare providers is raising public
awareness about the risk factors and consequences of CVDs. The Ministry of
Health and Population has launched public awareness campaigns on healthy
lifestyles and early detection of CVDs, targeting the general population,
healthcare professionals, and policymakers. These campaigns focus on the
importance of regular check-ups, healthy eating habits, physical activity, and quitting
smoking, alcohol, etc.
To reduce the incidence
of CVDs, the Egyptian government has implemented various programs to provide
early screening and diagnosis. For instance, the Ministry of Health and
Population offers free screening services for hypertension, diabetes, and
dyslipidemia, which are major risk factors for CVDs. The Ministry also provides
diagnostic tests such as electrocardiograms, echocardiograms, and stress tests
to identify patients with CVDs and initiate timely treatment. The Egyptian government has established specialized centers for CVD
treatment and management in various regions of the country. These centers
provide high-quality care and access to advanced medical technologies,
including invasive and non-invasive procedures for the diagnosis and treatment
of CVDs. The Egyptian government collaborates with
international organizations such as the World Health Organization (WHO) and the
International Society of Hypertension (ISH) to develop policies and strategies
for CVD prevention and control. These collaborations help in promoting
research, growing awareness, sharing best practices, and implementing
evidence-based interventions.
Download Free Sample Report
Market
Segmentation
Egypt
Cardiac Monitoring & Cardiac Rhythm Management Devices Market is segmented
based on the Type, End User, and Region. Based on type, the market is segmented
into cardiac monitoring devices and cardiac rhythm management devices. Based on
end users, the market is further fragmented into hospitals & clinics,
cardiac care centers, ambulatory surgery centers, and others.
Market Players
Medistim (Promed-Distributor),
Medtronic, Inc., Canadian Cardiac Care, Boston Scientific Corporation, St. Jude
Medical, Inc., Abbott Laboratories, BIOTRONIK SE & Co. KG, Terumo Corporation,
Biosense Webster Inc., GE Healthcare are some of the leading companies
operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 –
2022
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume Units and CAGR for 2018-2022
and 2023-2028
|
|
Report coverage
|
Revenue
forecast, Volume forecast company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
Type
End User
|
|
Regional scope
|
Alexandria, Suze Canal, Asyut region, Delta,
Greater Cairo & Upper North Region, South upper region
|
|
Key companies profiled
|
Medistim (Promed-Distributor),, Medtronic, Inc., Canadian Cardiac Care,
Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories,
BIOTRONIK SE & Co. KG, Terumo Corporation, Biosense Webster Inc., GE
Healthcare
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF
and Excel through Email (We can also provide the editable version of the
report in PPT/Word format on special request)
|
Report Scope:
In this report, Egypt Cardiac
Monitoring & Cardiac Rhythm Management Devices Market, 2028, has been
segmented into following categories, in addition to the industry trends which
have also been detailed below:
·
Egypt Cardiac Monitoring & Cardiac Rhythm
Management Devices Market, By
Type
o Cardiac Monitoring
Devices
o Cardiac Rhythm
Management Device
·
Egypt
Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User
o
Hospitals & Clinics
o
Cardiac Care Centers
o
Ambulatory Surgery Centers
o
Others
·
Egypt
Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By
Region:
o Alexandria
o Suze Canal
o Asyut region
o Delta
o Greater Cairo & Upper North
Region
o South upper region
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in Egypt Cardiac Monitoring & Cardiac Rhythm
Management Devices Market, 2028.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
Egypt Cardiac Monitoring & Cardiac Rhythm Management Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]